Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Cancer Cell. 2022 Jun 13;40(6):565-568. doi: 10.1016/j.ccell.2022.04.014. Epub 2022 May 12.
Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of treatment advances. We propose that the focus of translational research needs to shift from animal models to human patients, and the goal should be to understand why tumor responses and outcomes are so variable between patients and how it can be predicted at the individual level and thus to generate hypotheses that are more relevant to people than to atypically sensitive animal models.
动物模型已经发展成为癌症转化研究的一个关键组成部分,目前广泛用于测试候选药物、预测药物反应,实际上推动了癌症生物学的发现。然而,以模型为中心的方法并没有产生预期的大量治疗进展。我们提出,转化研究的重点需要从动物模型转移到人类患者,目标应该是了解为什么肿瘤反应和结果在患者之间如此多变,以及如何在个体水平上进行预测,从而产生更符合人类而非异常敏感的动物模型的假设。